Blog
No evidence to justify price increases for eight of top 10 most costly drugs
ICER’s latest Unsupported Price Increase report from the Institute for Clinical and Economic Review finds that, last year, eight of…
Analysis: Healthcare defies softening labor market
The post-COVID hot labor market is cooling in Connecticut and across the US. While some industries are still seeking qualified…
CT Medicaid Primary Care Redesign: What the Evidence Says Part 4: Better, Safer Options
Download the full report with sources Connecticut Medicaid is considering reforms to primary care delivery and payment. The CT Health…
Analysis: Medicare is Negotiating Drug Prices — Why it Matters
This is historic. Pharma has been fighting Medicare drug price negotiation for decades because it’s the start of reining in…
Book Club: Healthy Voices, Unhealthy Silence: Advocacy and Health Policy for the Poor
It was difficult to read Healthy Voices, Unhealthy Silence by Colleen Grogan and Michael Gusmano; thankfully it is short. It…
ICER seeking nominations for New England evidence review council
The Institute for Economic and Clinical Review (ICER) is seeking nominations for new members to the New England Comparative Effectiveness…
CT health systems ranked poorly by their nurses
Connecticut health systems underperform in an analysis of nurses’ satisfaction with their employers by MIT’s Sloan School of Management. Only…
ICER fair access report finds improvements but problems with transparency
ICER’s third annual Barriers to Fair Access report found that most prescription drug coverage policies met fair rules for patient…
Book Club: We’ve Got You Covered
I wasn’t looking forward to reading yet another book promoting yet another idea to solve America’s broken healthcare system. But…